How to Buy Neuroone Medical Technologies Stock
Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders.
Neuroone Medical Technologies stock last closed at $0.57, down 2.24% from the previous day, and has decreased 50.26% in one year. It has underperformed other stocks in the Medical Devices industry by 0.31 percentage points. Neuroone Medical Technologies stock is currently +43.54% from its 52-week low of $0.40, and -59.21% from its 52-week high of $1.39.
As of Apr 21, 2025, there are 30.86M NMTC shares outstanding. The market cap of NMTC is $17.50M. In the last 24 hours, 234,052 NMTC shares were traded.
How to Buy Neuroone Medical Technologies Stock
Wondering how to invest in Neuroone Medical Technologies stock? Here's how.
- Decide where to buy Neuroone Medical Technologies stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Neuroone Medical Technologies stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your investment account: Select your method of payment and add your details.
- Analyze Neuroone Medical Technologies stock: The Neuroone Medical Technologies ticker symbol is NMTC. Is Neuroone Medical Technologies stock a good investment? Should you buy shares of NMTC? How do NMTC's underlying business fundamentals look? Do top analysts think Neuroone Medical Technologies is a good buy? Why has NMTC's stock price moved recently? (Hint: Our stock research website can help you decide if NMTC is a good stock to buy).
- Execute your NMTC purchase: Decide if you will purchase NMTC shares at the current market price or use a limit order to purchase NMTC stock at a given price.
- Get the latest scoop on your NMTC investment: Create a watchlist to important updates regarding your investment in Neuroone Medical Technologies stock.
Step 1: Decide where to buy Neuroone Medical Technologies stock
You will need an online brokerage account to access the NASDAQ market and buy NMTC stock.
Our preferred brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Energy, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the best brokerage, the next step is to fill out some personal information so you can buy NMTC today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to start your new brokerage account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have opened your account on the best stock market app, your next step is to transfer the money for your investment:
Watch the walkthrough below if you need help transferring funds into your new brokerage account.
Step 4: Analyze Neuroone Medical Technologies stock
After you have chosen the best place to buy Neuroone Medical Technologies stock, it's crucial to analyze their stock before you invest, so you truly understand the risk and opportunity.
Overview of key NMTC info
Neuroone Medical Technologies Fundamentals
WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on NMTC's stock page.
How is NMTC stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NMTC's fair value.
Using relative valuations methods:
- NMTC may be overvalued based on its P/B ratio of 5.96x, relative to Medical Devices industry P/B ratio of 3.74x
You can access more valuation analysis on NMTC's stock here.
NMTC Financial Health
Pros:
- There are more short-term assets than short-term liabilities on the NMTC balance sheet.
- There are more short-term assets than long-term liabilities on the NMTC balance sheet.
- Total NMTC debt is lower than 5 years ago, relative to shareholder equity.
Cons:
- NMTC has cash burn of 7101882. It does not have enough cash and short-term investments to cover this.
- NMTC profit margin has gone up by 3.96 percentage points in the past year, but the company is still unprofitable.
- NMTC has $1.13M in cash and short term investments. This is not enough to cover its annual cash burn of $7.10M.
- NMTC has a relatively high debt to equity ratio of 1.21.
NMTC Technical Indicators
Is NMTC Growing Revenue?
Last year, NMTC revenue was $8.75M. During the last four year, NMTC's revenue has grown by 44.26% per year. This was faster than the Medical Devices industry average of 9.8%.
You can analyze NMTC's earnings and revenue performance here.
Latest Insiders Trades at NMTC
In the last year, insiders at NMTC have bought more shares than they have sold.
Ronald W. McClurg, Chief Financial Officer of NMTC, was the latest NMTC insider to buy. They bought $100,000.00 worth of NMTC shares on Apr 4, 2025.
Dig into more about who owns NMTC stock here.
Does NMTC provide a stable income stream?
No, Neuroone Medical Technologies doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your NMTC purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given price limit, place a limit order.
Click the Open Trade button and your broker will execute your order.
If you require additional assistance buying stocks on eToro, watch the helpful video below:
Step 6: Get the latest scoop on your NMTC investment
Now that you own some shares in NMTC, you'll want to keep up with your investment.
Start a watchlist to keep track of your NMTC stock.
NMTC Feed
How to Buy Stock in Neuroone Medical Technologies
To reiterate, here are the 6 steps to buy Neuroone Medical Technologies stock:
- Decide where to buy Neuroone Medical Technologies stock
- Create a brokerage account
- Fund your investment account
- Analyze Neuroone Medical Technologies stock
- Execute your NMTC purchase
- Get the latest scoop on your NMTC investment
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to watch your investment in Neuroone Medical Technologies, get started below.
Other Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.